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Introduction {#sec1}
============

Synaptic diversity is a generally accepted concept that embodies the functional, structural, and molecular heterogeneity of central synapses ([@bib2]; [@bib5]; [@bib7]; [@bib32]). The morphological heterogeneity of synapses was revealed over a half a century ago ([@bib13]). Probably still the most spectacular difference among central synapses is their enormous structural variations: e.g., most cortical axon terminals are ∼1 μm and possess a single active zone (AZ) with few release sites (RSs) versus the calyx of Held in the auditory brainstem that can be \>8 μm and form hundreds of AZs with thousands of RSs. Interestingly, combined functional and structural studies revealed that the overall morphology of the presynaptic axon terminal cannot be used to predict neither the quantal parameters---the number of RS (*N*) per AZ, the vesicle release probability (*Pv*), and the quantal size (*q*)---nor the type of short- or long-term plasticity ([@bib8]; [@bib16]; [@bib48]).

The most likely explanation of this is that differences in the molecular composition of synapses underlie the diversity in their function. Molecular studies revealed (reviewed by [@bib42]) multiple variants of key molecules essential for docking, priming, and fusion of synaptic vesicles (e.g., 3 Munc13 and 6 Munc18 variants), Ca^2+^ sensors (4 synaptotagmins), and presynaptic Ca^2+^ channels (3 Cav subunits). Similarly, there are 14 glutamate receptor (GluR) subunits that assemble into dozens of distinct GluRs with different affinities and kinetics. The combinatorial expression of only these pre- and postsynaptic molecules results in thousands of permutations, which could easily explain the observed functional diversity ([@bib29]).

How could we determine the molecular mechanisms underlying the functional diversity? A number of methods have been developed that allow the determination of gene and protein expression in brain areas, subregions, and even in individual cells (e.g., *in situ* hybridization, single-cell RT-PCR, single-cell RNA sequencing \[RNA-seq\], and proteomic analysis of synaptosomes; [@bib11]; [@bib12]; [@bib44]; [@bib46]). They are ideal for investigating the molecular mechanisms underlying differences in the functional properties of distinct synapse populations (e.g., cerebellar parallel fiber versus calyx of Held synapses). In these synapses, the pre- and postsynaptic elements belong to distinct cell classes with unique gene expressions. The up- or downregulation of genes in combination with functional analysis have been successfully used to reveal the roles of many synaptic proteins (reviewed by [@bib42]).

However, not only distinct synapse populations possess different functional properties. It has been demonstrated that the subunit composition of GluRs on a single postsynaptic cell can be presynaptic input dependent ([@bib9]; [@bib38]; [@bib47]). The functional properties and molecular composition of AZs of a single presynaptic cell could depend on the postsynaptic target cell type ([@bib1]; [@bib8]; [@bib20]; [@bib35]; [@bib39]; [@bib43]). Furthermore, the structural and functional properties of synapses made by identical pre- and postsynaptic cell types are also widely different (e.g., synapses among cerebellar interneurons \[INs\]; [@bib36]; or among hippocampal CA3 pyramidal cells \[PCs\]; [@bib15]). In these cases, population-level analysis of the functional properties and molecular content of synapses are inadequate; only individual synapse-based approaches are suitable.

What are the currently available high-resolution localization methods? The most widely used method is pre-embedding, light microscopy (LM) immunohistochemistry on thick (10--100 μm) sections. This method, however, is highly nonquantitative due to the differential diffusion of immunoreagents into the depth of the tissue. Only diffusion-free methods permit quantitative comparisons in the reaction strength of different subcellular elements. Freeze-fracture replica immunolabeling (FRL; [@bib10]; [@bib37]) has been widely used to localize transmembrane proteins at high resolution. This method is diffusion free, is linear, and has an exceptional sensitivity ([@bib22]); but, due to the random fracturing of the frozen tissue, so far none could use this method to study individual, functionally characterized synapses. Post-embedding immunolocalization on thin (∼100 nm) resin-embedded tissue sections is also diffusion free, is quantitative, and allows the visualization of antigens embedded in dense protein matrices (e.g., receptors embedded in the postsynaptic density \[PSD\]; [@bib28]; [@bib33]; [@bib34]). Researchers of previous studies ([@bib6]; [@bib25]; [@bib26]) have visualized the post-embedding reactions with fluorescent-dye-coupled secondary antibodies (sAbs), imaged them at the LM level, and performed the reactions on serial sections for post hoc reconstruction of the volume of the tissue (method called array tomography \[AT\]). They also demonstrated that the Abs can be eluted after a labeling round and that the sections can be relabeled, allowing the visualization of dozens of molecules. Probably the major shortcoming of AT was its limited sensitivity, and its application to functionally characterized synapses was challenging ([@bib45]). Here, we aim to overcome these limitations by optimizing fixation, resin, embedding, etching, retrieval, and elution conditions. We discovered that the highest sensitivity of the reactions was achieved in ordinary epoxy-resin-embedded tissue following etching and retrieval and also demonstrate the straightforward applicability of our method to functionally characterized synapses.

Results {#sec2}
=======

Etching Epoxy-Resin-Embedded Ultrathin Sections Dramatically Increases Immunolabeling {#sec2.1}
-------------------------------------------------------------------------------------

We performed post-embedding immunoreactions on cerebellar sections embedded into epoxy (Durcupan) or acrylic (LR White and Lowicryl HM20) resins without OsO~4~ treatment by using conventional protocols, and we visualized the reactions with fluorescent-dye-coupled sAbs. According to published results ([@bib26]), we detected punctate neuropil labeling for the soluble NSF attachment proteins receptors (SNARE) complex protein SNAP25 in the cerebellar molecular layer in acrylic-resin-embedded sections, without any detectable signal on the epoxy-resin-embedded sections ([Figure 1](#fig1){ref-type="fig"}A). It has been known that the strength of immunosignals in post-embedding reactions can be increased by etching the resin with Na-ethanolate (saturated solution of NaOH in absolute ethanol; [@bib17]; [@bib23]; [@bib31]; [@bib41]). Treating the 200-nm-thick sections with Na-ethanolate for 2--5 min before the immunoreactions dramatically increased the strength of the reaction in all three resin types tested ([Figure 1](#fig1){ref-type="fig"}B). Surprisingly, the reaction became the strongest in the epoxy-resin-embedded tissues. We also noticed that treating the etched sections with a 0.5% sodium dodecyl sulfate (SDS) solution at 80°C for 60 min further increased the reaction strength. Quantitative analysis of the reactions revealed that etching and retrieval increased the reaction strength by 4.0 ± 4.0, 7.5 ± 7.8, and 497.4 ± 565.0 times (n = 8 proteins; SNAP25, vGluT1, synaptotagmin 2, GFAP, PSD95, parvalbumin (PV), VGAT, and Piccolo) in LR White-, Lowicryl-, and Durcupan-embedded tissues, respectively. When we compared the reaction strength in LR White without etching to that in Durcupan with etching and retrieval, a 47.2 ± 72.4-fold increase was obtained (n = 8 proteins). Overall, we observed and increased reaction strength for a total of 65 proteins: 12 presynaptic molecules, 17 postsynaptic molecules, 3 calcium binding proteins, 3 neuropeptides, 8 structural proteins, 11 voltage-gated ion channels, 3 G-protein-coupled receptors, 5 transporters, and 3 cytoplasmic molecules ([Key Resources Table](#sec4.1){ref-type="sec"}). The strength of the reaction also depended on the chemical fixation of the tissue. We tested 1% and 4% formaldehyde (FA)-containing fixatives ([Table S1](#mmc1){ref-type="supplementary-material"}) and noticed that some molecules preferred stronger fixations (e.g., SNAP25 and vGluT1), whereas others preferred weaker fixations (e.g., PSD95, Piccolo, and NR1) and also some others were rather insensitive to fixation strength (e.g., CB1). Because the elution and restaining and the retention of biocytin in intracellularly filled cells were more reliable in 4% FA-fixed tissue, we decided to use this chemical fixation in the rest of the study.Figure 1Increased Immunolabeling Efficiency in Epoxy-Resin-Embedded Tissue after Etching and Antigen Retrieval(A and B) Post-embedding fluorescent labeling for SNAP25 on 200-nm-thin sections obtained from rat cerebellar cortex embedded into three different types of resin without (A) or with 2 min of etching with Na-ethanolate (B). All images were taken under the same illumination and detection conditions.(C) Munc13-1 immunolabeling of the stratum radiatum in epoxy-resin-embedded mouse hippocampal CA1 area after etching and retrieval. Reactions were carried out on sections with different thicknesses.(D) Normalized mean fluorescent signal intensity of PSD95, Munc13-1, and vGluT1 show a tight linear correlation with the section thickness. Symbols for each protein are the mean ± SD from 3 reactions in 3 mice. The reaction strengths were normalized to those obtained in the 200-nm-thick sections.(E) Immunofluorescence for vGluT1 in the stratum radiatum of the CA1 area (left image). Circular ROIs were placed over fluorescent clusters (ROI \#1--\#4) and over the unlabeled neuropil to determine the specific and background (bg) labeling, respectively. The reaction was followed by an elution step with 1% SDS (middle image) and a step when only the appropriate sAb (Alexa647 coupled donkey anti-rabbit) was applied (right image). All images were taken with the same acquisition settings and are shown with the same look-up table.(F) The integrated fluorescence (background-subtracted mean) is plotted for the 1^st^ labeling round, the elution, and the sAb relabeling steps. When the sAb was reapplied, the mean fluorescence did not increase significantly (1.4% ± 0.5% versus 2.3% ± 1.1% of the 1^st^ labeling round, n = 7, p = 0.99; while both significantly differed from the 1^st^ labeling round, p \< 0.0002, Kruskal-Wallis with Tukey honestly significant difference \[HSD\] post hoc test). Measurements for 7 proteins are shown, and symbols for each protein are the mean ± SD from 3 reactions in 3 mice from 20--50 ROIs per reaction.(G) Mean normalized PSD95 fluorescence is shown in 4 consecutive labeling rounds in epoxy-resin-embedded tissue obtained from 3 mice (open circles, 60, 69, and 73 ROIs in 3 reactions). The mean ± SD are shown with filled circles.(H) Same as in (G), but labeling for 4 proteins are shown (all represent the mean ± SD of 3 mice; 20--73 ROIs in each reaction).(I) The background-subtracted fluorescence of each ROI (same as in H) was calculated and normalized for the mean of each labeling round. Then, the ratio of the 2^nd^ and 1^st^ rounds was calculated for each ROI, and the mean and the coefficient of variation (CV) was calculated of these ratios. This was repeated for the 3^rd^ and 2^nd^ rounds and for the 4^th^ and 3^rd^ rounds. The symbols represent the mean ± SD from 3 reactions (3 mice).(J) The ratios of the background-subtracted fluorescent signal for vGluT1 and PSD95 and for Munc13-1 and PSD95 were calculated across 4 labeling rounds (27--30 ROIs in each experiment in 3 mice). Then, the ratios of the 2^nd^ and 1^st^, 3^rd^ and 2^nd^, and 4^th^ and 3^rd^ rounds were calculated. The round-to-round variability (CV) was then calculated and plotted.Open symbols represent the CV values of the 3 reactions in 3 mice, whereas filled symbols indicate the mean ± SD.Abbreviations are as follows: ml, molecular layer; pcl, Purkinje cell layer; gcl, granular layer.

In post-embedding reactions, the reaction strength should not depend on the thickness of the sections (e.g., 100 or 500 nm) because epitopes are accessible for the Abs only on the surface of the thin sections (e.g., top few nm). However, if the underlying mechanism of the increase in reaction strength by etching is that Na-ethanolate removes all resins and makes all epitopes within the entire section available for the Abs, then the reaction strength should show a positive correlation with the section thickness. We tested this hypothesis by cutting 70-, 100-, 200-, 300-, 400-, and 500-nm-thick sections and reacted them with PSD95, vGluT1, and Munc13-1 ([Figure 1](#fig1){ref-type="fig"}C). We then calculated the background-subtracted mean fluorescent intensities and normalized them to those of the 200-nm-thick sections. The almost perfect linear correlations between the actual and expected immunoreactivity for PSD95 and Munc13-1 with a slope of 1.03 and 1.02, respectively, demonstrate that Na-ethanolate entirely removes the epoxy resin from the sections, allowing the visualization of all epitopes within the section ([Figure 1](#fig1){ref-type="fig"}D). These results also provide evidence that the selected section thickness (within this range) is not a relevant factor when etching is performed: i.e., when the molecular content of a synapse is determined from 5 consecutive 100-nm sections or 1 500-nm section, the result should be the same.

Multiplexed Immunoreactions in Epoxy-Resin-Embedded Ultrathin Sections {#sec2.2}
----------------------------------------------------------------------

[@bib26] have elegantly demonstrated that multiple rounds of labeling can be performed on LR-White-embedded sections. We repeated their experiments in epoxy-resin-embedded sections and found that their elution solution (0.2 M NaOH for 20 min) consistently removed the sections from the coated histological slides. We then reduced the NaOH concentration to 0.02 M, which resulted in an incomplete removal of the immunoreagents. Increasing the temperature to 60°C fully removed the immunolabeling but caused some distortion of the sections. We then tested the effectiveness of a 1% SDS solution (pH = 9) at 80°C for 5 min and found that it efficiently abolishes the immunolabeling ([Figure 1](#fig1){ref-type="fig"}E). Quantitative analysis of 21 reactions for 7 different proteins revealed that after the elution only 1.4% ± 0.5% of the signal remained. The subsequent application of the appropriate sAbs did not significantly increase the signal (2.3% ± 1.1%; [Figure 1](#fig1){ref-type="fig"}F), demonstrating that our elution solution does not only quench the fluorescent molecules or remove only the sAb but also removes the primary Ab as well. Having established a reliable and effective way of removing the immunoreagents after a staining round, we repeated the labeling with new Abs in a way that the immunosignal in the new round should have had a different labeling pattern compared to the previous one ([Figures 2](#fig2){ref-type="fig"}A and 2B). We performed triple-labeling reactions with three primary Abs raised in different species in each labeling round and found qualitatively distinct labeling patterns either within or among the consecutive rounds (12 proteins in total; [Figures 2](#fig2){ref-type="fig"}A and 2B). To examine this quantitatively, we performed immunolabeling with two primary Abs (VGAT and PSD95) raised in the same species (Guinea pig) that label unique, nonoverlapping subcellular compartments ([Figure 2](#fig2){ref-type="fig"}C). We carried out single labeling first for PSD95 and imaged the hilar region of the hippocampus. Following an elution step, we immunolabeled the same section for VGAT, imaged the same area, and measured the fluorescence in regions of interest (ROIs) over excitatory synapses and VGAT-positive GABAergic axons. We then repeated these two steps and analyzed quantitatively the results. These experiments demonstrated that the fluorescence for VGAT was virtually zero over excitatory synapses in the PSD95 labeling rounds (1^st^ round: 2.6% ± 2.4% and 3^rd^ round: 4.6% ± 2.5%; n = 3), and similarly, the excitatory synapses remained unlabeled in the VGAT labeling rounds (2^nd^ round: 7.2% ± 1.1% and 4^th^ round: 5.7% ± 2.9%; [Figure 2](#fig2){ref-type="fig"}D).Figure 2Multiplexed Immunolabeling in Epoxy-Resin-Embedded Tissue after Etching and Antigen Retrieval(A) Multiple immunolabeling of an epoxy-resin-embedded section of the hippocampal CA1 area of an adult rat. Four rounds of triple labeling were performed using primary Abs raised in 3 different species (top row: mouse monoclonal IgG1; middle: rabbit polyclonal; bottom: Guinea pig polyclonal Abs). Reactions within one round were visualized with Alexa488-, Cy3-, and Cy5-coupled sAbs (all reactions are pseudocolored and shown in cyan). Boxed areas are shown at higher magnifications in panels (B~1~ and B~2~).(B~1~) Immunolabeling for PV, Kv2.1, VGAT, and vGluT1 are present in different, nonoverlapping subcellular compartments. The vGluT1-positive terminals are only present around the PV+ IN soma but not the neighboring PC somata that are outlined by the Kv2.1 labeling. VGAT-positive terminals (cyan) surround the somata of the IN and the PCs.(B~2~) Immunolabeling of PV, PSD95, CB1, and neuroligin-2 (NL-2).(C) Confocal images of a 200-nm-thick section of the mouse hilar region labeled for PSD95 (1^st^ and 3^rd^ rounds) and for VGAT (2^nd^ and 4^th^ rounds; both Guinea pig primary Abs). Circular ROIs were placed over PSD95-labeled glutamatergic synapses (yellow) and over VGAT-positive axons (cyan). The nonspecific background labeling (white ROI) was measured over the unlabeled neuropil.(D) Mean normalized integrated fluorescence values are plotted for 4 labeling rounds. Open symbols represent reactions from 3 mice, and the filled symbols are mean ± SD. The fluorescence in the inhibitory axons is 2.6% ± 2.4% in the 1^st^ and 4.6% ± 2.5% in the 3^rd^ rounds, similar to that measured over the excitatory synapses in the 2^nd^ (7.2% ± 1.1%) and 4^th^ (5.7% ± 2.9%) rounds. A total of 21--28 ROIs were analyzed in each condition.str. rad., stratum radiatum; str. pyr., stratum pyramidale.

Quantitative Analysis of Multiround Immunoreactions {#sec2.3}
---------------------------------------------------

It is crucial to understand how the absolute intensity of immunosignal changes along the consecutive labeling rounds because if there is a marked decrease in the intensity as the labeling rounds progress, some structures could eventually become erroneously immunonegative. We performed four rounds of immunolabeling for PSD95 in CA1 area and measured the intensity of glutamatergic synapses ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Quantitative analysis of the reactions disclosed very little change in the mean labeling intensity, although individual reactions showed slight increases or decreases ([Figures 1](#fig1){ref-type="fig"}G and [S1](#mmc1){ref-type="supplementary-material"}B). We repeated these experiments for three other proteins and found virtually no change in the reaction strength within the four rounds (2^nd^ round: 1.03 ± 0.09; 3^rd^: 1.00 ± 0.09; 4^th^: 1.03 ± 0.1; [Figure 1](#fig1){ref-type="fig"}H).

By using any immunolocalization technique, the absolute strength of the signal cannot be easily translated into a meaningful quantity because of the unknown labeling efficacy of the Abs. Therefore, most quantitative immunolocalization studies rely on the comparison of the immunoreactivity of distinct cellular or subcellular compartments (relative measures). If the ratio of the immunosignal between two sites reflects the ratio of the amount of molecules, one could claim that method as quantitative and linear. To investigate the reliability of our method for revealing quantitative differences in the strength of synapses, we calculated background-subtracted fluorescent intensities for dozens of excitatory synapses and normalized their values to the mean intensity in that round. We then repeated this procedure for four labeling rounds and calculated the ratios of the mean normalized fluorescent intensities for all ROIs between the 2^nd^ and 1^st^, the 3^rd^ and 2^nd^, and the 4^th^ and 3^rd^ rounds. The coefficient of variations (CVs) of these ratios provide an objective measure of the reliability of the labeling along the rounds. With other words, if a synapse in the 1^st^ round had an intensity of 50% of the mean and if it is still 50% of the mean in the 2^nd^ round, then the method provides a reproducible result. Such a situation would be characterized with a low CV value. [Figure 1](#fig1){ref-type="fig"}I illustrates that the CV for vGluT1 and PSD95 is less than 0.15 throughout the four rounds of labeling, demonstrating that very reliable labeling can be achieved with this method over many rounds. For the two additional Abs tested (Homer and panAMPAR) somewhat larger (0.4--0.5) CV values were obtained. Another way of assessing the reliability of multiround labeling is to calculate the round-to-round variance in the ratios of two synaptic proteins. We therefore performed double-labeling reactions for vGluT1 and PSD95 as well as Munc13-1 and PSD95 for four rounds. We then calculated the vGluT1/PSD95 and Munc13-1/PSD95 ratios for individual ROIs and computed their ratios between the 2^nd^ and 1^st^, the 3^rd^ and 2^nd^, and the 4^th^ and 3^rd^ rounds. [Figure 1](#fig1){ref-type="fig"}J demonstrates the small CVs, revealing again small round-to-round variations in the labeling.

Identification of Synaptic Proteins in Individual Synapses of Intracellularly Filled Neurons {#sec2.4}
--------------------------------------------------------------------------------------------

We have optimized the fixation, resin-embedding, etching, antigen retrieval, and elution conditions to obtain a sensitive, quantitative, diffusion-free immunolocalization method on ultrathin sections of unlabeled tissue. The golden aim in the field is to perform such a quantitative proteomic analysis in functionally characterized individual synapses. As a first step, we aimed to demonstrate that our method is compatible with widely used intracellular labeling techniques. We therefore performed whole-cell recordings from hippocampal CA1 PCs in acute slices from adult mice and filled the cells with biocytin. Following immersion fixation in a 4% FA-containing fixative, the biocytin was visualized with Cy3-coupled streptavidin and the cell was placed in conventional mounting medium for confocal imaging. [Figures 3](#fig3){ref-type="fig"}A and A′ show maximum intensity projection images of a segment of a PC apical oblique dendrite. The section was then dehydrated and flat embedded in Durcupan (without OsO~4~) for further imaging. To our surprise, the Cy3 molecules retained their fluorescence in the water-free environment of the epoxy resin. [Figures 3](#fig3){ref-type="fig"}A and A′ (middle panels) show the same dendritic segment acquired from the resin-embedded section. When we superimposed the images with rigid transformations, we observed that the dendrite and spines had the same overall morphology, but the dehydration caused some distortion ([Figure 3](#fig3){ref-type="fig"}A, right). When nonrigid transformations of the images were applied, we observed a perfect superimposition of the two images ([Figure 3](#fig3){ref-type="fig"}A′, right), demonstrating that the size and shape of the spines remained unchanged.Figure 3Multiplexed Immunolabeling of Synaptic Proteins in Intracellularly Filled Neurons(A and A′) Maximum intensity image of a biocytin-filled CA1 PC dendrite (visualized with Cy3-conjugated streptavidin) imaged in a 60-μm-thick section in an aqueous mounting medium (Slowfade Diamond, left). The same dendrite is shown in Durcupan (middle image). Superimposition of the two images with rigid transformations shows slight distortion (top right panel). However, the perfect superimposition of the two images (right image) with nonrigid transformation demonstrates that the overall morphology of the dendrites and dendritic spines remain the same following resin embedding (bottom right panel).(B) Maximum intensity projection of a confocal image stack of a biocytin-filled CA1 PC after dehydration and embedding in Durcupan. Arrowhead points to the main axon of an IN (oriens-lacunosum-moleculare \[O-LM\] cell shown in [Figure 6](#fig6){ref-type="fig"}).(C) High-magnification image of a selected dendritic segment in the epoxy-resin-embedded thick tissue. White arrowhead points to the IN axon.(C^∗^) The same dendritic segment as in (C), but after resectioning into a series of 200-nm sections. Images were aligned using "HyperStackStitcher" (see [STAR Methods](#sec4){ref-type="sec"}). Boxed area is enlarged in (D) and (D′).(D) Confocal image of the filled dendrite before (left) and after (middle) etching and antigen retrieval. Fluorescent labeling for PSD95 on the same section. Colored arrowheads indicate spines of different sizes and their quantitative results are shown in (E)--(G) (same color).(D′) Same as (D), but the next serial section.(E) The intensity of PSD95 immunolabeling of individual spines tightly correlates (R^2^ = 0.88, p = 5.2 × 10^−17^ Pearsons correlation, n = 36 spines) with that of biocytin, which is proportional to the volume of the spines.(F) Normalized PSD95 immunosignal of individual spines show tight correlation between the 1^st^ and the 5^th^ rounds (R^2^ = 0.94, p = 4.04 × 10^−18^ Pearsons correlation, n = 36).(G) Same as (E), but for immunolabeling with a panAMPAR Ab (R^2^ = 0.91, p = 4.03 × 10^−19^ Pearsons correlation, n = 36).

Not only small dendritic segments could be imaged in the resin-embedded tissue but also full reconstructions of intracellularly filled cells were possible ([Figure 3](#fig3){ref-type="fig"}B) by acquiring confocal Z image stacks from the full depth of ∼120-μm-thick sections. We selected an apical dendrite ([Figure 3](#fig3){ref-type="fig"}C) and re-embedded it for ultrathin sectioning. The Cy3 molecules emitted a sufficient amount of light in the 200-nm-thick sections so that the dendritic segments could be easily identified and imaged. The digital superimposition of 10 images of 10 consecutive 200-nm sections ([Figure 3](#fig3){ref-type="fig"}C^∗^) allowed the full reconstruction of the dendrite previously imaged in the 120-μm-thick section. On these ultrathin sections, we performed 5 rounds of labeling for 8 proteins. [Figure 3](#fig3){ref-type="fig"}D shows the labeling for PSD95 of spine synapses. Large synapses are labeled intensely, whereas small ones are weak. Two studies using EGFP-tagged PSD95 ([@bib4]; [@bib24]) demonstrated that the amount of PSD95 protein is proportional to the volume of the spine head. We therefore scrutinized our method by summing the integrated biocytin fluorescence and that of PSD95 from consecutive sections of individual spines (n = 36). The tight positive, linear correlation between these values ([Figure 3](#fig3){ref-type="fig"}E) is in agreement with the results of the above studies and provides strong evidence that our method is capable of revealing quantitative differences in the protein content of central synapses. PSD95 was labeled in the 1^st^ and relabeled in the 5^th^ round. [Figure 3](#fig3){ref-type="fig"}F illustrates a tight, positive correlation between these values, demonstrating again the reliability following the relabeling. A similar positive linear correlation was observed for AMPA-type GluRs (using a panAMPAR Ab; [Figure 3](#fig3){ref-type="fig"}G), consistent with the results obtained with post-embedding electron microscopy (EM) immunogold localization ([@bib31]). Similar significant positive correlations were observed for the presynaptic AZ proteins Munc13-1, Bassoon, Piccolo, and Rim 1/2 and for the PSD protein Homer, whereas the vGluT1 content of the axon terminal showed only a weak positive correlation with the spine volume ([Figure S2](#mmc1){ref-type="supplementary-material"}).

Molecular Analysis of Functionally Characterized Synapses {#sec2.5}
---------------------------------------------------------

Having established that biocytin can be visualized following embedding in epoxy resin, we set up three series of experiments to demonstrate the potentials of our method: i.e., to perform molecular analysis of functionally characterized individual synapses. First, we sparsely expressed iGluSnFR in CA1 PCs by using adeno-associated viral vectors (AAVs) expressing iGluSnFR in a Cre-dependent manner ([@bib21]) and highly diluted Cre-recombinase expressing AAVs. Whole-cell recordings were obtained from iGluSnFR-expressing PCs, and their axon collaterals were imaged using a two-photon microscope in line-scan mode ([Figures 4](#fig4){ref-type="fig"}A--4C). Somatic current-injection-evoked single action potentials (APs) either produced or failed to produce fast rising fluorescent transients in the scanned boutons. We calculated the failure rate (*P*~*f*~) for 4 boutons where a sufficiently large number of repetition was achieved ([Figure 4](#fig4){ref-type="fig"}D). Following the functional characterization, Z image stacks were acquired from the axon by using intracellularly applied Alexa594 as a fluorophore in the acute slice ([Figure 4](#fig4){ref-type="fig"}E). This was followed by chemical fixation and the visualization of biocytin with Cy3-coupled streptavidin. [Figure 4](#fig4){ref-type="fig"}F shows a maximum intensity projection image of the axon segment in thick epoxy-resin-embedded section, and the insets illustrate the boutons following resectioning at 200 nm (aligned with a custom-made module of ImageJ: HyperStackStitcher). The almost perfect match of the three image sets allowed us to identify the two-photon imaged boutons in the 200-nm sections. Following etching and antigen retrieval, we performed repeated labeling for a number of pre- and postsynaptic proteins in these functionally characterized boutons ([Figures 4](#fig4){ref-type="fig"}G and [S3](#mmc1){ref-type="supplementary-material"}). Although having analyzed only 4 boutons, the quantitative analysis revealed that the *P*~*f*~ negatively correlates with the total fluorescence of the biocytin (i.e., proportional to the volume of the boutons; [Figure 4](#fig4){ref-type="fig"}H) and with Munc13-1, Rim 1/2, and Piccolo, but not with Bassoon immunosignal ([Figure 4](#fig4){ref-type="fig"}I). The integrated biocytin intensity showd a positive correlation with the Munc13-1 ([Figure 4](#fig4){ref-type="fig"}J) and vGluT1 ([Figure 4](#fig4){ref-type="fig"}K) content of the boutons. Finally, our multiplexed immunolabeling also demonstrated that the PSD95 immunoreactivity adjacent to these boutons correlated positively with the Munc13-1 content of the presynaptic AZ and the AMPA receptor content of the PSD ([Figure 4](#fig4){ref-type="fig"}L).Figure 4Quantitative Analyses of Pre- and Postsynaptic Molecules in Synapses Characterized with iGluSnFR Imaging(A) Superimposed differential interference contrast (DIC) and fluorescent images of a CA1 PC that expresses the glutamate sensor iGluSnFR (green). The cell was filled with Alexa594 (25 μM) and biocytin (7 mM).(B) Low-magnification two-photon image of the Alexa594 signal of the basal dendritic tree and the imaged axon collateral of the PC.(C) High-magnification image of two boutons. Yellow line shows the path of the infrared laser beam (810 and 920 nm).(D) Single action potentials (APs) (top row) either fail (right) or evoke (left) detectable fluorescent transients. The numbers of successes and failures and the total number of repetitions are shown.(E) High-magnification maximum intensity projection image of a two-photon image stack of the axon. The failure rates (*P*~*f*~) of the 4 imaged boutons are shown.(F) Maximum intensity projection image of a confocal image stack showing the same axon after fixation and embedding in Durcupan (biocytin visualized with Cy3-coupled streptavidin). Three insets show the 4 boutons reconstructed from images of 200-nm-thick sections.(G) Multiplexed immunofluorescent labeling of a functionally characterized bouton (\#2) shown in (B)--(F). The biocytin signal is shown in the first image from the left with fire pseudocolor and blue in the remaining images. White oval ROI shows the position of the bouton. Presynaptic molecules are pseudocolored to green, while postsynaptic molecules are shown in red (for all 4 boutons see [Figure S3](#mmc1){ref-type="supplementary-material"}).(H) Failure rate (*P*~*f*~) of each bouton plotted against the intensity of the summed biocytin signal.(I) The same as (H), but for Bassoon, Piccolo, Rim 1/2, and Munc13-1.(J) Munc13-1 immunolabeling intensity shows a positive correlation with that of the biocytin.(K) The fluorescent intensity for biocytin is plotted against vGluT1 immunolabeling intensity.(L) PSD95 immunolabeling intensity is plotted against Munc13-1 and panAMPAR labeling.

Next, we combined *in vitro* two-photon \[Ca^2+^\] imaging with post hoc molecular analysis of axon terminals. CA1 PCs were whole-cell recorded in acute slices and were intracellularly filled with a Ca^2+^-insensitive fluorophore (Alexa594) and a Ca^2+^-sensitive one (100 μM Fluo5F) according to [@bib15] ([Figure 5](#fig5){ref-type="fig"}). Somatically evoked single APs and short trains of APs (5 AP at 40 Hz) either produced fast-rising, precisely time-locked \[Ca^2+^\] transients or failed to evoke fluorescent transients for single AP and evoked only slow-rising, small-amplitude transients for 5 APs ([Figure 5](#fig5){ref-type="fig"}B). To understand the potential molecular differences among these functionally distinct varicosities, we chemically fixed, dehydrated, and embedded the slice into Durcupan before resectioning at 200 nm. When we reacted the imaged boutons for vGluT1, all boutons were positive, but had variable amounts of fluorescence ([Figures 5](#fig5){ref-type="fig"}G and 5H), indicating that they were all synaptic-vesicle-containing varicosities. However, the boutons in which single APs failed to evoke \[Ca^2+^\] transients did not have detectable immunoreactivity either for Munc13-1 ([Figures 5](#fig5){ref-type="fig"}E and 5H) or for PSD95 ([Figures 5](#fig5){ref-type="fig"}F and 5H), demonstrating that these varicosities do not form functional synapses and the lack of AZ is consistent with the lack of voltage-gated Ca^2+^ channels ([@bib15]).Figure 5Quantitative Analysis of Pre- and Postsynaptic Molecules following Presynaptic \[Ca^2+^\] Measurements with Two-Photon Microscopy(A) Two-photon maximum intensity projection image of a local axon collateral of a CA1 PC filled with Alexa594 (25 μM), Fluo5F (100 μM), and biocytin. The scanned boutons (\#1--8) are indicated.(B) Fluorescent \[Ca^2+^\] transients in individual boutons evoked by single APs (top panel) or 5 APs (at 40 Hz, bottom panel; arrows indicate APs). Note that single AP-evoked rapid-rising \[Ca^2+^\] transients were not detected in boutons \#2, 3, 5, and 7.(C) Confocal image stack of the same axon collateral as in (A) after fixing and embedding in epoxy resin.(D) High-magnification confocal images of the boutons after resectioning at 200 nm. Bouton numbers correspond to those in (A) and (C). Images are from either single sections (middle and right panels) or maximum intensity projections of 2 consecutive sections (left panel).(E--G) Immunolabeling for Munc13-1 (E), PSD95 (F), and vGluT1 (G). Open white ROIs indicate the position of the boutons.(H) Normalized integrated fluorescent intensity values show that boutons with \[Ca^2+^\] transients (filled symbols, n = 4) have higher Munc13-1 and PSD95 labeling than boutons without single AP-evoked \[Ca^2+^\] transients (open symbols, n = 4), whereas all boutons contain vGluT1.

Finally, we performed dual whole-cell recordings between synaptically connected CA1 PCs and oriens-lacunosum-moleculare (O-LM) INs ([Figure 6](#fig6){ref-type="fig"}). A short train of presynaptic APs evoked excitatory postsynaptic currents (EPSCs) in CA1 O-LM cells that showed marked short-term facilitation ([@bib1]; [@bib3]; [@bib20]; [@bib35]; [@bib43]). To determine the quantal parameters, we performed multiple probability fluctuation analysis ([@bib3]; [@bib40]). This analysis requires a large change in the *P*~*v*~, which we achieved by increasing the extracellular \[Ca^2+^\] to 6 mM and subsequently applying phorbol 12,13-dibutyrate (1 μM; [Figures 6](#fig6){ref-type="fig"}A--6C). Following the functional characterization, the slice was fixed, dehydrated, and flat embedded in Durcupan before visual inspection of the close appositions between the presynaptic PC axon varicosities and the postsynaptic O-LM cell dendrites ([Figures 6](#fig6){ref-type="fig"}D and 6E). The presynaptic axon made only one close apposition with the postsynaptic dendrites, indicating that this functional connection is mediated by a single synapse ([Figure 6](#fig6){ref-type="fig"}F). We could also identify this synapse following resectioning at 200 nm ([Figures 6](#fig6){ref-type="fig"}G and 6H). The synapse was oriented tangentially to the sectioning plane and was present in a single 200-nm section. The presynaptic bouton was strongly vGluT1 immunopositive, and the opposition of the labeled pre- and postsynaptic structures contained fluorescent signal for PSD95 and AMPARs as well as Bassoon, Piccolo, and Munc13-1 ([Figure 6](#fig6){ref-type="fig"}I). Our results provide evidence that a single presynaptic AZ of a hippocampal CA1 PC can have as many as 10 RSs. This single AZ contains many of the known AZ-specific molecules, the quantitative relationship of which remains to be determined.Figure 6Identification of Pre- and Postsynaptic Molecules at a Physiologically Characterized Synapse between Two Synaptically Connected Neurons(A) Four APs (at 40 Hz) in a CA1 PC evoke EPSCs in a postsynaptic O-LM IN. The amplitude of the 1^st^ EPSC and the short-term plasticity pattern depend on the extracellular \[Ca^2+^\] (2 mM: dark purple, 6 mM: purple) and the presence of phorbol 12,13-dibutyrate (PDBU: 1 μM, pink). Traces are averaged from 30 consecutive traces at periods indicated in (B).(B) Plot of peak amplitude versus stimulus number demonstrates the time course of the effect of 6 mM \[Ca^2+^\] and applying PDBU.(C) Mean peak amplitude versus variance plot (measured for all 4 peak amplitudes in the 3 different conditions: black symbols). Fitting a parabola (red curve) to the data points allows the estimation of the number of functional release sites (*N*), quantal size (*q*), initial vesicle release probability (*Pv*~(ini)~), and maximum release probability (*Pv*~(max)~).(D) Low-magnification maximum intensity projection of a confocal image stack of the recorded cells (one PC in str. pyramidale and 2 O-LM INs in str. oriens) embedded into epoxy resin. Arrow points to the single contact site between the PC and the IN on the left.(E and F) Intermediate (E) and high (F) magnification views of the synaptic contact.(G) The synapse is shown after resectioning at 200 nm. Note that only those dendritic segments are shown that were in focus in (F).(H) Closest apposition of the biocytin filled bouton and IN dendrite is shown in a single 200-nm-thin section. White outlines help distinguishing the two profiles throughout the immunolabeled images.(I) The same section was immunolabeled for vGluT1, PSD95, Munc13-1, Bassoon, and Piccolo and for AMPA receptors (panAMPAR Ab) in 3 labeling rounds. Biocytin is shown with blue, and pre- and postsynaptic molecules are shown with green and red, respectively. vGluT1 immunosignal occupies most of the presynaptic bouton area, whereas the other 3 presynaptic molecules are more restricted toward the apposition of the pre- and postsynaptic structures.Abbreviations are as follows: str. l-m, stratum lacunosum-moleculare; str. ori., stratum oriens.

Super-Resolution Analysis of Multiplexed Reactions Using STED Microscopy {#sec2.6}
------------------------------------------------------------------------

One great advantage of visualizing post-embedding reactions with gold particles and examining them at the EM level is its superior resolution compared to conventional, diffraction-limited LM. However, super-resolution LM techniques have resolutions close to that of the size of the immunoglobulin Gs (IgGs) ([@bib14]), practically equaling the LM and EM analysis as far as the resolution is concerned. It was therefore our last aim to test our method for its applicability for stimulated emission depletion (STED) microscopy ([Figure 7](#fig7){ref-type="fig"}). First, we developed intracellularly filled cells with a mixture of Cy3- and Abberior635P (A635P)-coupled streptavidin. This combination allowed the visual inspection of the cells (using Cy3 channel) and the subsequent confocal (Cy3 and A635P) and STED (A635P) imaging of the filled processes. We found that using less than half of the 3 W of the 775-nm STED laser caused no damage of the thick, resin-embedded tissue, whereas increasing the STED laser power further could damage the resin-embedded tissue. Maximum intensity projection of confocal and STED images of a CA1 PC dendrite demonstrated the superior resolution of the STED microscopy, allowing the discrimination of spines from dendritic shafts ([Figures 7](#fig7){ref-type="fig"}A and 7C) and multiple closely spaced spine heads.Figure 7Super-Resolution Analysis of Epoxy-Resin-Embedded Neurons and Post-embedding Immunoreactions(A) Maximum intensity projection image of a confocal (left) and a STED image stack (right) obtained from a 70-μm-thick resin-embedded hippocampal tissue. Biocytin was visualized with A635P-coupled streptavidin. The white lines indicate the position of the line intensity scans shown in (C).(B) A putative IN dendrite located in the stratum radiatum is shown for 2 rounds of immunoreactions (1^st^: Munc13-1, green; 2^nd^: AMPA receptors, red). The reactions were visualized with A635P. STED image acquisition following the 1^st^ labeling round does not affect the immunolabeling of the 2^nd^ round. The white lines indicate the positions of the line scans shown in (D), (E), and (F).(C) Line intensity profiles of the confocal and STED images along the lines indicated in (A). Note that the separation of the spine from the dendritic shaft is impossible in the confocal but clearly possible in the STED image.(D) Intensity profile along the line indicated in (B) on the confocal and STED images over a strongly AMPA receptor immunoreactive PSD. Note that there is no detectable intensity inhomogeneity in the confocal, but there are 4 well-separated substructures in the STED image.(E and F) Line intensity profiles across a vertically cut synapse for Munc13-1 (E) and AMPA receptors (F).

We also performed STED imaging of the immunoreactions in 200-nm-thick sections. First, we carried out a Munc13-1 immunoreaction and developed it with Alexa488- and A635P-coupled sAbs. We acquired confocal images of both Alexa488 and A635P and a STED image of A635P of a presumed IN dendrite. In the section where the longitudinally cut IN dendrite had the largest diameter, excitatory synapses are aligned in a row on both sides of the dendrite and their orientation is mainly vertical to the cutting plane ([Figure 7](#fig7){ref-type="fig"}B). Following the image acquisition, a second round of staining was performed for Munc13-1 (developed with Alexa488 for alignment to the images to the previous round) and for AMPARs (panAMPAR Ab, developed with A635P). We reimaged the same IN dendrite and digitally superimposed the images based on the Munc13-1 images. The STED image acquisition with a five orders of magnitude higher intensity illumination power (2--3 W) compared to that of the excitation lasers (10--100 μW) caused no damage of the tissue section. We obtained strong labeling in the 2^nd^ round, demonstrating that our multiplexed method is fully compatible with STED imaging ([Figure 7](#fig7){ref-type="fig"}B). In the diffraction-limited confocal images, the separation of the individual synapses is more problematic than the higher resolution STED images. Such high-resolution imaging also allows the visualization of inhomogeneities in the labeling for Munc13-1 and AMPARs within tangentially cut AZs and PSDs, respectively, that have diameters close to the diffraction limit ([Figure 7](#fig7){ref-type="fig"}D).

Discussion {#sec3}
==========

In the present study, we demonstrate the development of a multiplexed, sensitive, diffusion-free, quantitative immunolocalization method that is ideal for molecular analysis of functionally characterized individual synapses.

AT is based on multiplexed immunoreactions on a series of acrylic-resin-embedded sections. It was a general wisdom that immunoreactions are superior in acrylic-resin-embedded tissues compared to those obtained in the most widely used epoxy resins. Therefore, most post-embedding EM immunogold localizations of neurotransmitter receptors, structural proteins, or ion channels have been performed on acrylic-resin-embedded tissue (reviewed by [@bib28]; [@bib33]; but see [@bib34]). Here, we also found that without etching the resins, only acrylic-resin-embedded tissues were suitable for localizing synaptic proteins, which is in agreement with the results of [@bib6]. However, when the resins were etched with Na-ethanolate and were then treated with SDS, a dramatic increase in the strength of reactions was observed. To our surprise, the highest intensity signal was obtained in osmium-free epoxy-resin-embedded tissue (∼50-fold increase in Durcupan versus LR White).

Embedding tissue into Lowicryl HM20 is usually carried out at low temperatures (−90°C to −45°C) in large blocks and requires special equipment, whereas embedding into Durcupan (or other epoxy resins) is performed at room temperature without the need of any special equipment. Embedding into LR White is routinely performed in tissue blocks, and it is not used for so-called flat embedding (i.e., embedding a 60- to 100-μm-thick section between a glass slide and a coverslip), which is essential for LM identification of functionally characterized synapses and their consequent EM or LM molecular analysis. Although [@bib45] identified synapses in LR-White-embedded large tissue blocks, it requires the resectioning of the whole block and 3D reconstructing and inspecting the entire tissue block from thousands of sections, which necessitate special software tools. Thus, the two key technical developments (etching with Na-ethanolate and antigen retrieval with SDS) allow the use of epoxy resins with all of their advantages but still permit the most efficient immunolabeling.

One of the greatest breakthrough of AT, as developed by [@bib26], is the demonstration of multiple rounds of immunolabeling (multiplexing), allowing the analysis of dozens of proteins in the same subcellular structures, such as synapses. The multiplexed immunolabeling requires the elution of the immunoreagents before the next round of labeling. We repeated the elution method of [@bib27] and found that a 0.2 M NaOH solution removed the epoxy-resin-embedded sections from the glass slides. Fortunately, we found that a 1% SDS solution at 80°C efficiently removes (\>98%) both the primary Abs and sAbs but keeps the immunogenicity of the tissue intact, allowing further rounds of immunolabeling. This efficient elution step is an essential prerequisite of relabeling of the tissue in consecutive labeling rounds with new sets of Abs. Our quantitative analysis with 4 synaptic proteins revealed that on average there is no change in the absolute strength of the immunoreactions, at least for 4 labeling rounds, ensuring that false negativity in later rounds is not a concern.

An additional benefit of performing the reactions and imaging ultrathin sections is the dramatic increase in spatial resolution with which the reaction can be examined. Diffraction-limited confocal LM has lateral and axial resolutions of ∼250 and ∼600 nm, respectively. By using 3D STED imaging, these resolutions can be dramatically (∼40-fold) reduced to ∼100 nm in each dimension (e.g., Abberior Expert Line system with a 3-W STED laser). The axial resolution in post-embedding reactions is defined by the thickness of the sections, which was mainly 200 nm in our reactions but can be easily reduced to 70 nm (see [Figure 1](#fig1){ref-type="fig"}C). Thus, when imaging ultrathin sections, we do not need to use 3D but only 2D STED, which has a superior lateral resolution (∼30 nm) compared to its 3D variant. This results in an additional 16-fold improvement in resolution compared to the 3D STED (30 × 30 × 70 nm versus 100 × 100 × 100 nm) and a 600-fold improvement compared to conventional confocal imaging. Furthermore, imaging ultrathin sections that are in direct contact with the coverslip possess all optical means that warrants the best theoretical resolution of LM (e.g., lack of refractive index mismatch in the thick tissue). Indeed, we regularly achieve lateral resolutions of \<35 nm in our tissue sections ([Figure 7](#fig7){ref-type="fig"}D) that is close to that (∼30 nm) measured with fluorescent 20-nm beads.

A major advantage of post-embedding immunoreactions on thin sections is that the immunoreagents do not have to penetrate into the tissue and proteins in all subcellular locations can be recognized by the Abs. This is in stark contrast to the widely used pre-embedding reactions where molecules embedded into the thick protein matrix of the PSD or axon initial segments remain unreachable for immunoglobulins unless some special antigen retrieval method is applied ([@bib9]; [@bib18], [@bib19]; [@bib47]). For example, if antigen retrieval with pepsin treatment is required, the digestion of the thick tissue will show a depth-dependent gradient that also precludes quantitative comparisons. Irrespective of whether antigen retrieval is used or not, diffusion into the thick tissue always imposes a gradient in the reaction strength; therefore, the intensity difference between two subcellular compartments does not reflect the difference in their antigen content. For these reasons, pre-embedding immunoreactions are clearly not quantitative. Probably the best method for comparing the protein content of two distinct membrane areas is FRL ([@bib22]; [@bib37]). Here, proteins are "freely" hanging out from the replica, as there is no diffusion barrier for the Abs, allowing them to access their target proteins with equal probability. However, because the fracturing of the tissue is random, it seems impossible to direct the fracturing plane through a functionally characterized synapse, making this technique inadequate for a direct function and molecular content comparison. The only other diffusion-free immunolocalization method is post-embedding immunoreactions on ultrathin sections. Although this method is generally perceived to have lower sensitivity than FRL or the widely used pre-embedding methods, the introduction of etching and SDS treatment dramatically improves on this shortcoming while keeping its known advantages.

Probably the most important finding of the present work and the greatest advantage of our method is that it is ideal for performing molecular analysis on functionally characterized synapses. Here, we provided three sets of experiments as a demonstration that we could determine the relative protein content of individual synapses after *in vitro* fluorescent glutamate or \[Ca^2+^\] imaging and also following paired recordings. All these determinations rely on our ability to visualize intracellularly filled neurons at the LM level in thick resin-embedded sections. Finding the *in vitro* two-photon imaged bouton strings is not necessarily straightforward, but identifying all synaptic contact between a presynaptic and postsynaptic cell is clearly a formidable challenge. This requires a thorough visual inspection of the cells under epifluorescent illumination that lasts for hours. An important technical point is that the fluorescence of Cy3 molecules in epoxy resin is stable even after hours of constant illumination, allowing consequent confocal and STED imaging. By performing quantitative immunolocalization of functionally characterized boutons, here, we revealed that axon varicosities, which do not possess fast-rising, precisely AP time-locked \[Ca^2+^\] transients, contain vGluT1-expressing synaptic vesicles but have undetectable presynaptic AZ molecules. Because presynaptic Ca^2+^ channels are confined to the AZ, the lack of AZ fully explains the lack of large amplitude, fast rising \[Ca^2+^\] transients. Furthermore, we also demonstrated using *in vitro* fluorescent glutamate sensor imaging that the *P*~*f*~ of glutamate release from hippocampal CA1 PC axon terminals is inversely proportional to the amount of Munc13-1 molecule in the AZ. Finally, using paired recordings and variance analysis, we provided unequivocal evidence that a single presynaptic AZ of a CA1 PC axon terminal could contain as many as 10 functional RSs.

Post-embedding immunolocalization at single synapse resolution will clearly not substitute the widely used high-throughput techniques (e.g., *in situ* hybridization, RT-PCR, RNA-seq, and proteomic analysis) that are capable of monitoring the expression of thousands of genes and proteins. However, these methods do not have the resolution of a single synapse; therefore, research addressing the molecular mechanism underlying the functional diversity of individual synapses requires a quantitative, multiplexed method that has the spatial resolution of a single synapse. Our currently developed methods are very unlikely to allow the quantitative analysis of the whole synaptome, but dozens of carefully selected, functionally relevant proteins can be quantitatively localized with spatial resolutions of 10s of nanometers. Thus, *in situ* hybridization, single-cell RNA-seq, and proteomic analysis of a large population of synapses paired with this multiplexed post-embedding localization technique form a technical toolbox essential for understanding the molecular mechanisms underlying synaptic diversity.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse monoclonal IgG1 anti-Ankyrin-GNeuroMabCat\#75-187; RRID: [AB_2057718](nif-antibody:AB_2057718){#intref0010}Chicken polyclonal anti-BassoonSynaptic systemsCat\#141-016; RRID: [AB_2661779](nif-antibody:AB_2661779){#intref0015}Rabbit polyclonal anti-BassoonSynaptic systemsCat\#141003; RRID: [AB_887697](nif-antibody:AB_887697){#intref0020}Mouse monoclonal IgG2a anti-BassoonENZOCat\#PS003-D; RRID: [AB_1659574](nif-antibody:AB_1659574){#intref0025}Guinea pig polyclonal anti-beta-CateninSynaptic systemsCat\#281004; RRID: [AB_2661781](nif-antibody:AB_2661781){#intref0030}Mouse monoclonal IgG1 anti-CalbindinNeuroMabCat\#73-448; RRID: [AB_2619740](nif-antibody:AB_2619740){#intref0035}Mouse polyclonal anti-CalretininSwantCat\#6B3; RRID: [AB_10000320](nif-antibody:AB_10000320){#intref0040}Guinea pig polyclonal anti-Cav2.1Synaptic systemsCat\#152 205; RRID: [AB_2619842](nif-antibody:AB_2619842){#intref0045}Rabbit polyclonal anti-Cav2.1Synaptic systemsCat\#152 203; RRID: [AB_2619841](nif-antibody:AB_2619841){#intref0050}Rabbit polyclonal anti-Cav2.3Synaptic systemsCat\#152 403; RRID: [AB_2619848](nif-antibody:AB_2619848){#intref0055}Mouse monoclonal IgG1 anti-Cav3.1NeuroMabCat\#75-206; RRID: [AB_2069421](nif-antibody:AB_2069421){#intref0060}Guinea pig polyclonal anti-CB1FrontiersCat\#Af530; RRID: [AB_2314113](nif-antibody:AB_2314113){#intref0065}Mouse monoclonal IgG2b anti-CB1Synaptic systemsCat\#258 011; RRID: [AB_2619969](nif-antibody:AB_2619969){#intref0070}Rabbit polyclonal anti-CB1Synaptic systemsCat\#258 003; RRID: [AB_2619970](nif-antibody:AB_2619970){#intref0075}Rabbit polyclonal anti-CCKSigmaCat\#C2581; RRID: [AB_258806](nif-antibody:AB_258806){#intref0080}Rabbit polyclonal anti-ERC1b/2Synaptic systemsCat\#143 003; RRID: [AB_887715](nif-antibody:AB_887715){#intref0085}Mouse monoclonal IgM anti-GABAA a1Synaptic systemsCat\#224 211; RRID: [AB_2619928](nif-antibody:AB_2619928){#intref0090}Rabbit polyclonal anti-GABAA a6Synaptic systemsCat\#224 603; RRID: [AB_2619945](nif-antibody:AB_2619945){#intref0095}Rabbit polyclonal anti-GABAA b1Synaptic systemsCat\#224 703; RRID: [AB_2619939](nif-antibody:AB_2619939){#intref0100}Rabbit polyclonal anti-GABAA b2Synaptic systemsCat\#224 805; RRID: [AB_2619942](nif-antibody:AB_2619942){#intref0105}Rabbit polyclonal anti-GABAA b3Synaptic systemsCat\#224 403; RRID: [AB_2619935](nif-antibody:AB_2619935){#intref0110}Rabbit polyclonal anti-GABAA dW. Sieghartd(1-44)R5Mouse monoclonal IgG1 anti-GephyrinSynaptic systemsCat\#147 021; RRID: [AB_2232546](nif-antibody:AB_2232546){#intref0115}Mouse monoclonal IgG1 anti-GFAPSigmaCat\#G3893; RRID: [AB_477010](nif-antibody:AB_477010){#intref0120}Guinea pig polyclonal anti-GLASTChemiconCat\#AB1783; RRID: [AB_90959](nif-antibody:AB_90959){#intref0125}Mouse monoclonal IgG1 anti-GluA1NeuroMabCat\#75-327; RRID: [AB_2315840](nif-antibody:AB_2315840){#intref0130}Rabbit polyclonal anti-GluA2Synaptic systemsCat\#182 103; RRID: [AB_2113732](nif-antibody:AB_2113732){#intref0135}Guinea pig polyclonal anti-GluA4FrontierCat\#GluA4N-GP; RRID: [AB_2571756](nif-antibody:AB_2571756){#intref0140}Guinea pig polyclonal anti-HCN1FrontierCat\#HCN1-GP-Af540; RRID: [AB_2650995](nif-antibody:AB_2650995){#intref0145}Rabbit polyclonal anti-Homer 1b/cSynaptic systemsCat\#160-023; RRID: [AB_2619858](nif-antibody:AB_2619858){#intref0150}Chicken polyclonal anti-Homer 1Synaptic systemsCat\#160-006; RRID: [AB_2631222](nif-antibody:AB_2631222){#intref0155}Rabbit polyclonal anti-Iba1WakoCat\#019-19741; RRID: [AB_839504](nif-antibody:AB_839504){#intref0160}Rabbit polyclonal anti-IDH3AProteintechCat\#15909-1-AP; RRID: [AB_2123282](nif-antibody:AB_2123282){#intref0165}Guinea pig polyclonal anti-Kv1.1FrontierCat\#Kv1.1-GP; RRID: [AB_2571788](nif-antibody:AB_2571788){#intref0170}Rabbit polyclonal anti-Kv1.1FrontierCat\#Kv1.1-Rb; RRID: [AB_2571787](nif-antibody:AB_2571787){#intref0175}Rabbit polyclonal anti-Kv1.2FrontierCat\#Kv1.2-Rb; RRID: [AB_2571789](nif-antibody:AB_2571789){#intref0180}Mouse monoclonal IgG1 anti-Kv2.1NeuroMabCat\#75-014; RRID: [AB_10673392](nif-antibody:AB_10673392){#intref0185}Guinea pig polyclonal anti-Kv4.2AlomoneCat\#AGP-038; RRID: [AB_2340969](nif-antibody:AB_2340969){#intref0190}Mouse monoclonal IgG1 anti-Kv4.3NeuroMabCat\#75-017; RRID: [AB_2131966](nif-antibody:AB_2131966){#intref0195}Rabbit polyclonal anti-Kv3.1bSynaptic systemsCat\#242 003; RRID: [AB_11043175](nif-antibody:AB_11043175){#intref0200}Guinea pig polyclonal anti-M2 mAChRFrontierCat\#mAchR-M2-GP; RRID: [AB_2571792](nif-antibody:AB_2571792){#intref0205}Mouse monoclonal IgG2b anti-Myelin Basic ProteinMilliporeCat\#MAB387; RRID: [AB_240843](nif-antibody:AB_240843){#intref0210}Rabbit polyclonal anti-mGluR1aFrontierCat\#mGluR1a-Rb; RRID: [AB_2571799](nif-antibody:AB_2571799){#intref0215}Guinea pig polyclonal anti-mGluR1aFrontierCat\#mGluR1a-GP; RRID: [AB_2571801](nif-antibody:AB_2571801){#intref0220}Rabbit polyclonal anti-MoverSynaptic systemsCat\#248 003; RRID: [AB_10804285](nif-antibody:AB_10804285){#intref0225}Guinea pig polyclonal anti-Munc13-1Synaptic systemsCat\#126 104; RRID:[AB_2619806](nif-antibody:AB_2619806){#intref0230}Rabbit polyclonal anti-Munc13-1Synaptic systemsCat\#126-103; RRID: [AB_887733](nif-antibody:AB_887733){#intref0235}Rabbit polyclonal anti-Nav1.6AlomoneCat\#ASC-009; RRID: [AB_2040202](nif-antibody:AB_2040202){#intref0240}Rabbit polyclonal anti-N-CadherinSynaptic systemsCat\#363 003; RRID: [AB_2620123](nif-antibody:AB_2620123){#intref0245}Mouse monoclonal IgG1 anti-NeuNMilliporeCat\#MAB377; RRID: [AB_2149209](nif-antibody:AB_2149209){#intref0250}Rabbit polyclonal anti-Neuroligin-2Synaptic systemsCat\#129-203; RRID: [AB_993014](nif-antibody:AB_993014){#intref0255}Mouse monoclonal IgG2a anti-GluN1MilliporeCat\#MAB363; RRID: [AB_94946](nif-antibody:AB_94946){#intref0260}Mouse monoclonal IgG2b anti-GluN2BNeuroMabCat\#75-101; RRID: [AB_2232584](nif-antibody:AB_2232584){#intref0265}Guinea pig polyclonal anti-panAMPARFrontiersCat\#Af580; RRID: [AB_257161](nif-antibody:AB_257161){#intref0270}Mouse monoclonal IgG1 anti-pan-NeurofascinNeuroMabCat\#75-027; RRID: [AB_10672370](nif-antibody:AB_10672370){#intref0275}Rabbit polyclonal anti-ParvalbuminSwantCat\#PV28; RRID: [AB_2315235](nif-antibody:AB_2315235){#intref0280}Rabbit polyclonal anti-PiccoloSynaptic systemsCat\#142-113; RRID: [AB_2619830](nif-antibody:AB_2619830){#intref0285}Guinea pig polyclonal anti-PiccoloSynaptic systemsCat\#142 104; RRID: [AB_2619831](nif-antibody:AB_2619831){#intref0290}Guinea pig polyclonal anti-PSD95Synaptic systemsCat\#124-014; RRID: [AB_2619800](nif-antibody:AB_2619800){#intref0295}Rabbit polyclonal anti-Rim 1/2Synaptic systemsCat\#140-203; RRID: [AB_887775](nif-antibody:AB_887775){#intref0300}Guinea pig polyclonal anti-SERTFrontierCat\#HTT-GP; RRID: [AB_2571777](nif-antibody:AB_2571777){#intref0305}Rabbit polyclonal anti-Shank3Synaptic systemsCat\#162 302; RRID: [AB_2619862](nif-antibody:AB_2619862){#intref0310}Guinea pig polyclonal anti-Shank3Synaptic systemsCat\#162 304; RRID: [AB_2619863](nif-antibody:AB_2619863){#intref0315}Mouse monoclonal IgG1 anti-SNAP25Synaptic systemsCat\#111-001; RRID: [AB_887793](nif-antibody:AB_887793){#intref0320}Rabbit polyclonal anti-SNAP25AlomoneCat\#ANR-001; RRID: [AB_2040196](nif-antibody:AB_2040196){#intref0325}Rat polyclonal anti-SomatostatinMilliporeCat\#MAB354; RRID: [AB_2255365](nif-antibody:AB_2255365){#intref0330}Rabbit polyclonal anti-Synapsin IMilliporeCat\#AB1543; RRID: [AB_2200400](nif-antibody:AB_2200400){#intref0335}Rabbit polyclonal anti-Synaptotagmin 2Synaptic systemsCat\#105 123; RRID: [AB_2199465](nif-antibody:AB_2199465){#intref0340}Rabbit polyclonal anti-Synaptotagmin 7Synaptic systemsCat\#105 173; RRID: [AB_887838](nif-antibody:AB_887838){#intref0345}Rabbit polyclonal anti-SynCAM 1/2/3Synaptic systemsCat\#243 003; RRID: [AB_10804052](nif-antibody:AB_10804052){#intref0350}Mouse monoclonal IgG1 anti-SyntaxinSigmaCat\#S0664; RRID: [AB_477483](nif-antibody:AB_477483){#intref0355}Rabbit polyclonal anti-VAChTFrontierCat\#VAChT-Rb; RRID: [AB_2571850](nif-antibody:AB_2571850){#intref0360}Guinea pig polyclonal anti-VGATSynaptic systemsCat\#131-004; RRID: [AB_887873](nif-antibody:AB_887873){#intref0365}Rabbit polyclonal anti-vGluT1Synaptic systemsCat\#135-302; RRID: [AB_887877](nif-antibody:AB_887877){#intref0370}Guinea pig polyclonal anti-vGluT1ChemiconCat\#AB5905; RRID: [AB_2301751](nif-antibody:AB_2301751){#intref0375}Guinea pig polyclonal anti-vGluT2MilliporeCat\#MAB5504; RRID: [AB_2187552](nif-antibody:AB_2187552){#intref0380}Guinea pig polyclonal anti-VIPPeninsulaCat\#T-5030; RRID: [AB_518690](nif-antibody:AB_518690){#intref0385}Rabbit polyclonal anti-ZO-1ThermofisherCat\#61-7300; RRID: [AB_2533938](nif-antibody:AB_2533938){#intref0390}Donkey anti-rabbit Secondary antibody, Alexa488JacksonCat\# 711-545-152, RRID:[AB_2313584](nif-antibody:AB_2313584){#intref0395}Goat anti-mouse IgG1 Secondary antibody, Alexa488JacksonCat\# 115-545-205, RRID:[AB_2338854](nif-antibody:AB_2338854){#intref0400}Donkey anti-Guinea pig Secondary antibody, Alexa488JacksonCat\# 706-545-148, RRID:[AB_2340472](nif-antibody:AB_2340472){#intref0405}Donkey anti-Chicken Secondary antibody, Alexa647JacksonCat\# 703-605-155, RRID:[AB_2340379](nif-antibody:AB_2340379){#intref0410}Donkey anti-Guinea pig Secondary antibody, Alexa647JacksonCat\# 706-605-148, RRID:[AB_2340476](nif-antibody:AB_2340476){#intref0415}Donkey anti-rabbit Secondary antibody, Alexa647JacksonCat\# 711-605-152, RRID:[AB_2492288](nif-antibody:AB_2492288){#intref0420}Donkey anti-mouse IgG1 Secondary antibody, Alexa647JacksonCat\# 115-605-205, RRID:[AB_2338916](nif-antibody:AB_2338916){#intref0425}Donkey anti-Rabbit Secondary antibody, Cy3JacksonCat\# 711-165-152, RRID:[AB_2307443](nif-antibody:AB_2307443){#intref0430}Donkey anti-Guinea pig Secondary antibody, Cy3JacksonCat\# 706-165-148, RRID:[AB_234046](nif-antibody:AB_234046){#intref0435}Goat anti-Mouse Secondary antibody, Cy3JacksonCat\# 115-165-003, RRID:[AB_2338680](nif-antibody:AB_2338680){#intref0440}Goat anti-Mouse IgG1 Secondary antibody, Cy3JacksonCat\# 115-165-205, RRID:[AB_2338694](nif-antibody:AB_2338694){#intref0445}Goat anti-Mouse IgG2a Secondary antibody, Cy3JacksonCat\# 115-165-206, RRID:[AB_2338695](nif-antibody:AB_2338695){#intref0450}Goat anti-Mouse IgG2b Secondary antibody, Cy3JacksonCat\# 115-165-207, RRID:[AB_2338696](nif-antibody:AB_2338696){#intref0455}Goat anti-rat Secondary antibody, Cy3JacksonCat\# 112-165-003, RRID:[AB_2338240](nif-antibody:AB_2338240){#intref0460}Goat anti-Guinea pig Secondary antibody, Abberior STAR 635PAbberiorCat\#2-0112-007-1Goat anti-rabbit Secondary antibody, Abberior STAR 635PAbberiorCat\#2-0012-007-2Goat anti-chicken Secondary antibody, Abberior STAR 635PAbberiorCat\#2-0102-007-4Streptavidin Cy3 coupledJacksonCat\# 016-160-084, RRID:[AB_2337244](nif-antibody:AB_2337244){#intref0465}Streptavidin Abberior STAR 635P coupledAbberiorCat\#2-0205-007-0**Bacterial and Virus Strains**AAV9.hSyn.Flex.iGluSnFr. WPRE.SV40Penn Vector CoreN/AAAV9.CamKII0.4.Cre.SV40Penn Vector CoreN/A**Chemicals, Peptides, and Recombinant Proteins**KetamineProdulab Pharma B.V.\#2302/2/07, 10%XylasineProdulab Pharma B.V.\#2303/3/07, 20 mg / mLPipolpheneEGIS Gyógyszergyár Zrt.\#OGYI-T-3086/01, 25 mg / mLSucroseSigma-AldrichCat\#S5016KClSigma-AldrichCat\#P3911NaHCO3Sigma-AldrichCat\#S6014CaCl2Sigma-AldrichCat\#C5080MgCl2Sigma-AldrichCat\#M2670NaH2PO4Sigma-AldrichCat\#S0751glucoseSigma-AldrichCat\#G7528NaClSigma-AldrichCat\#S9888K-gluconateSigma-AldrichCat\#P1847Cesium methanesulfonateSigma-AldrichCat\#C1426Creatinine phosphateSigma-AldrichCat\#27920HEPESSigma-AldrichCat\#H7523ATP disodium saltSigma-AldrichCat\#A2383GTP sodium saltSigma-AldrichCat\#G8877biocytinSigma-AldrichCat\#B4261EGTASigma-AldrichCat\#E0396AlexaFluor594InvitrogenCat\#A10438Fluo5FInvitrogenCat\#F14221QX314TocrisCat\#2313Phorbol 12,13-di-butyrateTocrisCat\#4153ParaformaldehydeMolar ChemicalsCat\#BC0487491ParaformaldehydeEMSCat\#19208Uranyle AcetateTAABCat\#U008Durcupane ACM Resin Single component ASigma-AldrichCat\#44611Durcupane ACM Resin Single component BSigma-AldrichCat\#44612Durcupane ACM Resin Single component CSigma-AldrichCat\#44613Durcupane ACM Resin Single component DSigma-AldrichCat\#44614Picric acidSigma-AldrichCat\#197378Lowicryl HM20EMSCat\#14340LR WhiteSigma-AldrichCat\#62662Triton X-100VWR ChemicalsCat\#9002-93-1Slowfade DiamondInvitrogenCat\#S36967Tris BaseSigma-AldrichCat\#252859Tris HClSigma-AldrichCat\#T3253NaH~2~PO~4~Sigma-AldrichCat\#S0751Na~2~HPO~4~Sigma-AldrichCat\#S9763Sytox greenInvitrogenCat\#S7020BlottoASanta Cruz BiotechnologyCat\#Sc2333Normal goat serum (NGS)Vector LaboratoriesCat\#S-1000Bovine serum albumin (BSA)Sigma-AldrichCat\#A2153**Experimental Models: Organisms/Strains**Wistar ratCharles River GermanyCat\# 737929, RRID:RGD_737929Mouse C57Bl6/JJacksonCat\# JAX:000664, RRID:IMSR_JAX:000664Mouse FVBAnt (FVB.129P2-*Fmr1*^*tm1Cgr*^/J strain)JacksonCat\# JAX:004828, RRID:IMSR_JAX:004828Mouse Tg(Chrna2-Cre)OE25Gsat/MmucdJacksonRRID:MMRRC_036502-UCDMouse Ai9 (Gt(ROSA)26Sor_CAG/LSL_tdTomato)JacksonCat\# JAX:007909, RRID:IMSR_JAX:007909**Software and Algorithms**ImageJNational Institute of Health<https://imagej.nih.gov/ij>; RRID: [SCR_003070](rridsoftware:SCR_003070){#intref0475}Hyperstack stitcher (ImageJ plugin)This paper, 3D Histech<http://www.nusserlab.hu/>Mes v4.6Femtonics<https://femtonics.eu/>Adobe Photoshop CS3Adobe<https://www.adobe.com/hu/products/photoshop.html>Origin 2018OriginLab<https://www.originlab.com/>Multiclamp (version 2.1)Axon Instruments/Molecular Devices<https://www.moleculardevices.com/>Statistica 13.4StatSoft<https://www.tibco.com/products/data-science>Clampex (version 10.3)Axon Instruments/Molecular Devices<https://www.moleculardevices.com/>**Other**Vibratome VT1200SLeica<https://www.leica-microsystems.com/>Ultramicrotome EM UCTLeica<https://www.leica-microsystems.com/>Abberior Instruments Expert Line STED microscopeAbberior Instruments<https://www.abberior.com/>Olympus FV1000 Confocal microscopeOlympus<https://www.olympus-lifescience.com/en/>Femto 2D microscopeFemtonics<https://femtonics.eu/>Mai Tai femtosecond pulsing laserSpectra-Physics<https://www.spectra-physics.com/>Nikon Eclipse FN1 microscopeNikon<https://www.nikon.com/>Multiclamp 700B amplifierAxon Instruments/Molecular Devices<https://www.moleculardevices.com/>Superfrost Ultra plus slideThermoscientific<https://www.thermofisher.com/us/en/home/brands/thermo-scientific.html>DMZ Zeits PullerZeitz<https://www.zeitz-puller.com/>PapPenThermoFisher ScientificCat\# 008899Borosilicate glass capillarySutter InstrumentsCat\# BF150-86-10

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Zoltan Nusser (<nusser@koki.hu>).

### Materials Availability {#sec4.2.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec4.2.3}

Any raw data supporting the current study is available from the Lead Contact upon request. The code and user manual of the Hyperstack Stitcher module of the ImageJ can be downloaded from the laboratory website: <http://www.nusserlab.hu/>

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Animals {#sec4.3.1}

Four young-adult Wistar rats (P21 -- P60), 12 adult (P50 -- 85) male and female C57Bl6 mice, and 10 adult (P44 -- 70) male FVBAnt mice, 1 P55 Tg(Chrna2-Cre)OE25Gsat/Mmucd, (RRID:MMRRC_036502-UCD, on C57Bl6 background) crossed with reporter line Ai9 (Gt(ROSA)26Sor_CAG/LSL_tdTomato) mice were used. The animals were housed in the vivarium of the Institute of Experimental Medicine in a normal 12 h/12 h light/dark cycle and had access to water and food *ad libitum*. All the experiments were carried out in accordance with the Hungarian Act of Animal Care and Experimentation (1998, XXVIII, section 243/1998) and with the ethical guidelines of the Institute of Experimental Medicine Protection of Research Subjects Committee.

Method Details {#sec4.4}
--------------

### Virus injection {#sec4.4.1}

Mice were anaesthetized with a mixture of ketamine, xylasine, pypolphene (0.625, 6.25, 1.25 mg / ml respectively, 10 μl / g body weight). AAV9.hSyn.Flex.iGluSnFr. WPRE.SV40 (1.43^∗^10^13^, Penn Vector Core; [@bib21]) combined with 1:5000 dilution of AAV9.CamKII0.4.Cre.SV40 (2.8^∗^10^13^, Penn Vector Core) were injected into the dorsal hippocampus (200 nl, coordinates from the Bregma in mm: antero posterior 2.1 dorso ventral 1.1 lateral 1.3). After 3 weeks, *in vitro* acute slices were cut from the dorsal hippocampus as below.

### Slice preparation and electrophysiological recordings {#sec4.4.2}

Mice were stably anaesthetized with a ketamine, xylasine, pypolphene cocktail (0.625, 6.25, 1.25 mg / ml respectively, 10 μl / g body weight) decapitated, the brain was quickly removed and placed into an ice-cold cutting solution containing the following (in mM): sucrose, 205.2; KCl, 2.5; NaHCO~3~, 26; CaCl~2~, 0.5; MgCl~2~, 5; NaH~2~PO~4~, 1.25; and glucose, 10, saturated with 95% O~2~ and 5% CO~2~. Three hundred micron thick coronal slices were then cut from the dorsal part of the hippocampus using a Leica Vibratome (VT1200S) and were incubated in a submerged-type holding chamber in ACSF containing the following (in mM): NaCl, 126; KCl, 2.5; NaHCO~3~, 26; CaCl~2~, 2; MgCl~2~, 2; NaH~2~PO~4~, 1.25; and glucose, 10, saturated with 95% O~2~ and 5% CO~2~, pH 7.2--7.4, at 36°C for an hour, then kept at 22 -- 24°C until use. Recordings were performed in the same ACSF either at 22 -- 24°C (2-photon imaging, and \[Ca^2+^\] was increased to 6 mM for iGluSnFR imaging) or 32°C (paired recording) up to 6 h after slicing.

Cells were visualized using either a Femto2D microscope equipped with oblique illumination and a water-immersion lens (25X, numerical aperture (NA) = 1.05, Olympus) or with an infrared differential interference contrast (DIC) using a Nikon Eclipse FN1 microscope with a 40X water immersion objective (for paired recording). CA1 PCs were identified by their morphology, O-LM INs were identified using fluorescent illumination and TdTomato expression in Chrna2-Cre x Ai9 animals. Whole-cell current-clamp recordings were performed from CA1 PCs of the dorsal hippocampus using MultiClamp 700B amplifiers (Molecular Devices). Recorded traces were filtered at 3--4 kHz and digitized online at 20 kHz. Patch pipettes (resistance 3--6 MΩ) were pulled from thick-walled borosilicate glass capillaries with an inner filament. Intracellular solution contained the following (in mM): K-gluconate, 110; KCl, 5; creatine phosphate, 10; HEPES, 10; ATP, 2; GTP, 0.4; and biocytin, 5, pH 7.3; 290--300 mOsm. EGTA (0.05 mM) was included in the intracellular solution for iGluSnFR imaging and paired recording, but was omitted from \[Ca^2+^\] imaging. For two-photon glutamate-imaging, 25 μM AlexaFluor594 (Invitrogen) and for \[Ca^2+^\] imaging, 25 μM AlexaFluor594 and 100 μM Fluo5F (Invitrogen) were also added to the intracellular solution. Pyramidal cells were held at −65 mV (with a maximum of ± 100 pA DC current) and single or multiple APs were evoked with 2 -- 3 ms-long depolarizing current pulses (1--1.2 nA). Peak amplitude and full width at half-maximal amplitude of the APs were monitored and cells were rejected if any of these parameters changed ˃10%. Paired whole-cell recordings were performed with a dual-channel amplifier (MultiClamp 700B; Axon Instruments). Data were filtered at 3 or 4 kHz (Bessel filter), digitized on-line at 20 kHz, recorded and analyzed using pClamp 10.3 (Molecular Devices). Postsynaptic INs were filled with intracellular solution that contained the following (in mM): Cs-methanesulfonate, 135; CsCl, 4; MgCl~2~, 4; EGTA, 0.05; creatine phosphate, 10; HEPES, 10; ATP, 2; GTP, 0.4; and biocytin, 5, pH 7.3; 290--300 mOsm. INs were held at −70 mV (with a maximum of ± 200 pA DC current) in voltage-clamp mode. Multiple probability fluctuation analysis was carried out according to [@bib3] and [@bib40].

### Two-photon laser scanning microscopy {#sec4.4.3}

Experiments were performed with a Femto2D (Femtonics) laser scanning microscope equipped with a MaiTai femtosecond pulsing laser tuned to 810 nm and a Coherent Chameleon Vision S femtosecond pulsing laser tuned to 920 nm (for iGluSnFR imaging). Electrophysiological data and image acquisition were controlled with a software (Mes, Femtonics). For detailed methods of Ca^2+^-imaging see [@bib8] and [@bib15]. Briefly cells were filled for 2 h with a Ca^2+^-insensitive (25 μM AlexaFluor594) and a Ca^2+^-sensitive fluorophore (100 μM Fluo5F). Boutons were selected at 150 -- 300 μm distances from the soma, imaged in line scan mode (at 1 kHz, 1 per minute repetition, two scans (one for 1 AP and one for 5 APs) for each bouton) with a laser intensity of 2 -- 6 mW at the back aperture of the objective lens. Single AP-evoked changes in fluorescence were recorded. For iGluSnFR imaging, boutons were identified using the Ca^2+^-insensitive fluorophore AlexaFluor594, and glutamate transients were recorded simultaneously at 920 nm (6 - 12 mW at the back aperture, scanning at 1 kHz, 1 per minute repetition, 15 - 20 scans for each bouton).

### Tissue processing {#sec4.4.4}

After recordings, the slices were fixed in a solution containing 4% formaldehyde (FA, Molar Chemicals), 0.2% picric acid in 0.1 M phosphate buffer (PB), pH = 7.4, at 4°C for 12h. Slices were embedded in agarose (2%) and re-sectioned at 120 --150 μm thickness. Biocytin was visualized with Cy3- (Jackson Laboratories) or A635P-conjugated streptavidin (Abberior Instruments, 1:1000) diluted in Tris-buffered saline (TBS) containing 0.2% Triton X-100. Sections were treated with 1% uranyl acetate (in distilled water (DW)) for 25 minutes, dehydrated between a glass slide and a coverslip in a graded series of ethanol (50%, 70%, 90%, 96%, 2x 100%) for 10 minutes each with constant dropping the solutions, with final incubations in acetonitrile for 2 × 13 minutes in vials and flat embedded in epoxy resin, which was prepared by the standard mixing of the Durcupan components (A:B:C:D, 10:10:0.3:0.3 g each) overnight at room temperature and cured at 60°C for 48 hours. First, the recorded cells / cell pairs were analyzed at high magnifications (60X or 100X objective; numerical aperture = 1.35) and the imaged boutons or potential synaptic contacts were identified by visual inspection. Identified structures were re-embedded and serial (50 −150 sections in a ribbon) ultrathin (200 nm thickness) sections were cut and placed onto Superfrost Ultra plus slides and left on a hotplate at 60°C for 30 minutes then at 80°C overnight (modified from [@bib26]). Adherence of sections in ribbons were helped if necessary with pattex glue applied to the lower side of the block. Filled presynaptic and postsynaptic profiles, and axonal segments were followed from section to section at high magnifications and imaged using a confocal microscope (Olympus FV1000) prior to sequential immunolabeling. The 3D volume was reconstructed from the serial sections using a newly developed ImageJ plugin (HyperStackStitcher, 3DHistech). The plugin and the documentation is available at the laboratory website (<http://www.nusserlab.hu/>).

### Processing of perfusion fixed tissue {#sec4.4.5}

Young adult (P21 -- 25) Wistar rats (n = 4) and adult (P44 -- 70) FVBAnt wild-type mice (n = 10) were deeply anaesthetized and transcardially perfused with fixative containing 1 or 4% FA (Molar Chemicals or Electron Microscopy Sciences) and 0.2% picric acid in 0.1 M PB for 15 -- 25 min. The brains were then quickly removed from the skull and placed in 0.1 M PB. Next, 60 -- 100 μm thick sections were cut from the dorsal hippocampus and cerebellum. Sections (for epoxy resin embedding) or pieces of tissues (for Lowicryl HM20 and LR White embedding) were washed several times in 0.1 M PB, dehydrated (without prior treatment with OsO~4~) and embedded in LR White according to [@bib26], Lowicryl HM20 ([@bib30]) or Durcupan ([@bib15]). 200 nm thick serial sections were cut using a Histo Jumbo diamond knife (Diatome) and placed onto Superfrost Ultra plus slides and left on a hotplate at 60°C for 30 min, then at 80°C overnight. Slides were stored prior to the immunoreactions for up to several months at room temperature.

### Etching the resin, retrieval and sequential immunofluorescent labeling {#sec4.4.6}

Sections were encircled with PapPen (Life Technologies) to keep incubating solutions on the slides. The resin was etched with Na-ethanolate, which is a saturated solution of NaOH in absolute ethanol (dissolve 40 g of NaOH pellets in 100 mL of absolute ethanol and let the solution stand at room temperature for 2 weeks before use). After 5 minutes of etching at room temperature (different times were also tested) sections were rinsed with 96% ethanol three times, then with DW. Retrieval of the proteins were carried out in 0.02M Tris Base (pH = 9) containing 0.5% sodium dodecyl sulfate (SDS) at 80°C for 60 min (different times were also tested, and 60 minutes were found to be the optimum for most of the proteins). After several washes in TBS containing 0.05 -- 0.1% Triton X-100 (TBST, pH = 7.6), sections were blocked in TBST containing 6% BlottoA (Santa Cruz Biotechnology), 10% normal goat serum (NGS, Vector Laboratories) and 1% BSA (Sigma) for 30 minutes then incubated in the primary Abs diluted in blocking solution at room temperature overnight with gentle agitation. The primary Abs used for illustrations and are shown in the figures are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. All tested Abs that gave specific immunolabeling with our method are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. After several washes in TBST the sAbs were applied in TBST containing 10% of blocking solution for 2 hours. The following sAbs were used in the present study: Alexa488-, Alexa 647-, Cy3-, Cy5- (Jackson), Abberior635P- (Abberior) coupled goat or donkey anti-mouse, anti-rabbit, anti-Guinea pig, anti-chicken, anti-rat IgGs (1:200 or 1:400 dilutions, see [Key Resources Table](#sec4.1){ref-type="sec"}). After several washes in TBST sometimes Sytox green (1:200 in TBST, Thermofisher) was also applied to stain nuclei for alignment of serial sections. Slides were rinsed in DW then sections were mounted in Slowfade Diamond (Invitrogen). Images of selected structures were taken with confocal microscope (Olympus FV1000 or Abberior Instruments Expert Line on an Olympus BX63 microscope). Immunolabeling was removed with 5 minutes incubation in TBS containing 1% SDS (pH = 7.7) at 80°C. After 5 minutes wash in TBST a new round of immunolabeling could be performed.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Quantitative image analysis {#sec4.5.1}

Confocal images were imported in ImageJ where circular ROIs were placed over synaptic fluorescent clusters and over the unlabeled neuropil to determine the nonspecific, background labeling. The integral of the fluorescence was measured and the background was subtracted for each ROI. Images of the serial 200 nm thick sections were aligned using a custom-made module of ImageJ ('HyperStackStitcher'; available on the web site: <http://nusserlab.hu/software.html>).

For the quantitative analysis of immunoreactions of sections with different thickness or different fixatives, a rectangular ROI was placed over the area of the stratum radiatum and the background subtracted mean intensity values were measured. For quantitative analysis of immunoreactions of sections from different resins, 3 -- 5 rectangular ROIs were placed over the area of the stratum moleculare, Purkinje cell layer, or the granule cell layer of the cerebellum depending on the labeling pattern, and the background subtracted mean intensity values were measured.

### Statistical analyses {#sec4.5.2}

Data is presented as mean ± SD throughout the MS. For comparisons of three conditions (e.g., immunosignal at 1^st^ labeling, after elution and re-staining with sAb only; [Figure 1](#fig1){ref-type="fig"}F) statistical difference were determined by Kruskal-Wallis test with Tuckey honest significant difference (HSD) post hoc correction. Correlation between different immunolabeling intensities ([Figure 3](#fig3){ref-type="fig"}; [Figure S2](#mmc1){ref-type="supplementary-material"}) were assessed using Pearsons correlation after testing the data distribution for normality.
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